Market Outlook

By 2035, the U.S. Large Volume Infusion Pumps Market is expected to reach approximately USD 2.74 billion, expanding at a CAGR of approximately 8.8% during the forecast period 2026–2035. The market is estimated at USD 1.18 billion in 2025, following expansion from approximately USD 0.89 billion in 2021, USD 0.94 billion in 2022, USD 1.02 billion in 2023, and USD 1.10 billion in 2024. Values in this report are expressed in USD billions.

For market-sizing purposes, the U.S. large volume infusion pumps market includes large-volume infusion pump hardware, dedicated administration-set revenue economically attributable to installed LVP platforms, infusion safety and connectivity software, pump-related accessories, implementation services, and recurring service revenue. This scope reflects how U.S. health systems actually procure and evaluate modern infusion platforms rather than treating the pump console as an isolated capital device.

Large volume infusion pumps are among the most operationally embedded medical technologies in U.S. acute care. They are used to administer hydration fluids, antibiotics, vasoactive agents, electrolytes, parenteral nutrition, chemotherapy-supportive therapies, blood products, anesthetic drugs, and numerous other intravenous treatments across intensive care units, emergency departments, medical-surgical floors, operating rooms, oncology units, pediatric departments, and specialty care environments.

The fundamental demand base is large. U.S. hospitals operate more than 900,000 staffed beds, while annual hospital admissions exceed 34 million. At the same time, hospital expenditures surpassed USD 1.63 trillion in 2024, illustrating the scale of the clinical infrastructure through which infusion therapy is delivered. Large volume infusion pumps therefore represent a relatively small percentage of hospital capital spending but an unusually important component of medication administration workflow.

The 2026–2035 growth cycle will be less dependent on simple additions to pump counts and more dependent on fleet replacement, smart-pump modernization, electronic health record interoperability, drug-library compliance, cybersecurity upgrades, wireless fleet management, multi-channel efficiency, and recurring dedicated-set economics. Hospitals are increasingly replacing pumps as enterprise platforms rather than purchasing individual units for isolated departments.

Competition is also entering a more dynamic phase. Updated BD Alaris systems, Baxter’s Novum IQ platform, ICU Medical’s newer Plum precision systems, Fresenius Kabi’s Ivenix platform, and B. Braun’s infusion systems are creating a meaningful technology replacement cycle. Each competes not only on pumping accuracy but on nurse usability, interoperability, alarms, medication safety, biomedical engineering workload, cybersecurity, drug-library management, implementation support, and total lifecycle cost.

The market could reach approximately USD 1.28 billion in 2026, USD 1.52 billion in 2028, USD 1.80 billion in 2030, USD 2.13 billion in 2032, and USD 2.74 billion by 2035 if current replacement and connectivity trends are sustained.

 

Introduction

According to the U.S. Large Volume Infusion Pumps Market Report, the industry is moving from conventional infusion-device purchasing toward integrated medication-management infrastructure. A modern large volume pump functions as both a fluid-delivery device and a digital endpoint inside the hospital medication-administration ecosystem.

Large volume infusion pumps, often described as volumetric infusion pumps, typically deliver larger quantities of intravenous fluids at controlled rates than syringe pumps. Their clinical role extends from routine crystalloid administration to complex infusions requiring accurate rate control, standardized medication libraries, configurable alarms, and continuous clinical monitoring.

Demand is structurally tied to the size and acuity of the U.S. hospital system. There are more than 913,000 staffed hospital beds nationally, and large health systems increasingly operate standardized fleets extending across multiple facilities. An enterprise deployment can involve thousands of pumps, multiple software environments, dedicated administration sets, biomedical service agreements, pharmacy drug-library configuration, network infrastructure, nurse education, and EHR integration. This creates substantial switching costs and makes each contract strategically important to manufacturers.

Medication safety is a second defining characteristic. Historical FDA experience with infusion pumps has demonstrated that software defects, mechanical failures, alarm problems, user-interface weaknesses, and programming errors can create clinically significant risks. Modern smart pumps therefore incorporate dose error reduction software, configurable drug libraries, hard and soft dosing limits, wireless connectivity, event logs, and increasingly bidirectional interoperability with electronic medical records.

The U.S. market is also entering a replacement cycle shaped by technology availability. Several leading manufacturers have introduced, relaunched, remediated, or expanded LVP platforms since 2023. This is giving hospital procurement committees more credible alternatives and encouraging health systems to reassess legacy fleets that may have been retained longer than originally intended.

A key economic characteristic of the market is the relationship between capital equipment and recurring consumables. Manufacturers may compete aggressively for pump placement because the installed fleet creates continuing demand for compatible administration sets, software, maintenance, accessories, training, and service. Consequently, procurement evaluation frequently examines a five-to-ten-year economic period rather than the initial pump acquisition price alone.

The next decade will increasingly reward platforms capable of demonstrating low programming burden, high drug-library compliance, reliable integration, manageable alarm behavior, strong cybersecurity, efficient fleet servicing, and predictable consumable supply. In a labor-constrained U.S. hospital environment, a pump that saves nursing or biomedical engineering time can generate economic value beyond the traditional device-price comparison.

 

Key Market Drivers: What’s Fueling the U.S. Large Volume Infusion Pumps Market Boom?

The strongest market driver is the enormous baseline volume of intravenous therapy delivered across the American hospital system. With more than 34 million hospital admissions annually, IV medications and fluids are part of routine care across emergency medicine, critical care, surgery, oncology, infectious disease, pediatrics, and general inpatient medicine. Large volume pumps therefore benefit from recurring utilization rather than depending on one narrow clinical specialty.

Critical care represents an especially important demand engine. Sepsis contributes to an estimated 1.7 million adult hospitalizations annually in the United States, with approximately 350,000 patients dying during hospitalization or being discharged to hospice. Management frequently requires controlled delivery of antibiotics, fluids, vasopressors, electrolytes, sedatives, insulin, and other high-alert medications. While not every infusion is delivered through an LVP, the scale and complexity of sepsis management illustrate why reliable infusion infrastructure remains essential in acute care.

A second driver is hospital fleet replacement. Large health systems increasingly treat infusion pumps as enterprise technology assets. A replacement decision can involve hundreds or thousands of devices and generally requires multidisciplinary assessment by nursing, pharmacy, biomedical engineering, information technology, cybersecurity, supply chain, medication-safety teams, and hospital finance.

The replacement environment has become more active as multiple manufacturers offer contemporary smart-infusion platforms. Procurement teams that previously had limited practical alternatives are increasingly able to compare touchscreen workflows, modular versus stand-alone architectures, secondary-infusion functionality, drug-library management, wireless capability, interoperability, battery performance, service models, and administration-set economics.

A third driver is the increasing priority placed on medication safety. Smart pumps with dose error reduction software can warn clinicians when programmed doses or rates fall outside predefined institutional parameters. This technology is particularly valuable when administering high-alert medications such as anticoagulants, insulin, vasoactive agents, sedatives, opioids, electrolytes, and selected oncology drugs.

Smart-pump penetration is already mature in U.S. hospitals, but maturity does not eliminate growth. It changes the source of growth from first-time adoption to next-generation replacement and workflow optimization. The strategic question for hospitals is increasingly whether their infusion system communicates efficiently with pharmacy, nursing documentation, barcode medication administration, and the electronic health record.

EHR interoperability represents a fourth major growth driver. Auto-programming can transfer verified medication-order information from the patient’s electronic record to the infusion pump, reducing manual transcription steps. Auto-documentation can return infusion information to the clinical record. Together, these capabilities support a more closed-loop medication process and can improve data consistency while reducing repetitive nursing work.

A fifth driver is nursing productivity. U.S. hospitals continue to operate in an environment where clinical labor is expensive and nurse time is constrained. Device interfaces requiring excessive keystrokes, difficult secondary-infusion setup, frequent nuisance alarms, complicated channel management, or time-consuming troubleshooting can create hidden operating costs. Procurement committees are increasingly evaluating pump platforms through workflow observation and human-factors testing rather than technical specifications alone.

A sixth driver is U.S. oncology demand. Approximately 2.04 million new cancer cases were expected in the United States in 2025. Although many chemotherapy regimens use specialized infusion systems, large volume pumps remain relevant for hydration, supportive medications, antibiotics, electrolytes, parenteral nutrition, blood products, and selected oncology infusions across cancer centers and hospital oncology units.

A seventh driver is recurring consumable economics. Dedicated pump administration sets generate repeat utilization following hardware placement. Consequently, manufacturers compete for installed-base share because the lifetime economic value of the customer can significantly exceed the initial pump purchase. Hospital buyers increasingly model this relationship themselves, comparing per-set pricing, annual set consumption, standardization potential, waste, availability, and contract escalation clauses.

Finally, U.S. hospital spending provides a large addressable economic base. Hospital expenditures reached approximately USD 1.63 trillion in 2024, making medication-delivery infrastructure a relatively modest but clinically indispensable category. Hospitals may defer certain discretionary capital purchases during periods of financial pressure, but infusion fleet replacement becomes difficult to postpone when aging equipment creates reliability, safety, serviceability, cybersecurity, or support risks.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in large volume infusion pumps is shifting from basic pumping accuracy toward integrated medication administration. Flow-rate performance remains fundamental, but competitive differentiation increasingly depends on whether the system can simplify a nurse’s workflow and operate reliably inside the hospital’s digital environment.

Smart-pump interoperability is one of the most commercially important innovation areas. The industry is progressing toward bidirectional communication between infusion devices and EHR systems. When implemented effectively, this can reduce manual pump programming and improve infusion documentation. Manufacturers that demonstrate compatibility with major U.S. electronic health record environments can gain an important advantage in large integrated delivery networks.

User-interface design is another competitive frontier. Newer platforms increasingly use larger displays, touchscreen controls, graphical prompts, simplified programming sequences, and workflow logic designed around contemporary consumer-device expectations. Hospitals are placing greater emphasis on reducing programming complexity because the usability of thousands of routine infusions has direct implications for nurse efficiency and medication safety.

Multi-channel capability is also evolving. Modular systems allow hospitals to add infusion channels to a common control architecture, while newer independent or cassette-based configurations attempt to provide channel flexibility without excessive bedside hardware. The preferred architecture differs by clinical environment. Intensive care often requires several simultaneous infusions, whereas general medical-surgical units may prioritize portability, simplicity, and low setup burden.

Secondary-infusion management remains an important area of differentiation. Traditional IV piggyback workflows can create height dependence, clamp-position errors, incomplete secondary delivery, and workflow complexity. Systems that simplify primary and secondary administration or provide more independent channel control can offer practical nursing advantages.

Fleet intelligence is becoming more valuable. Wireless connectivity can enable remote drug-library updates, pump-status monitoring, software management, alarm and event analysis, and device-location workflows. Large hospitals may operate thousands of infusion assets, making visibility into fleet utilization and maintenance status strategically important.

Cybersecurity has moved from an information-technology consideration to a core medical-device procurement requirement. Connected infusion pumps become network endpoints and must be evaluated for authentication, software updates, vulnerability management, network architecture, access control, patching, and long-term vendor support. Hospital cybersecurity teams are therefore playing a more prominent role in infusion-system purchasing decisions.

Manufacturers are also investing in analytics. Infusion data can reveal drug-library compliance, alert frequency, overrides, unusual programming patterns, clinical-area differences, and training opportunities. Hospitals increasingly want actionable dashboards rather than raw event logs. Analytics that identify recurring workflow problems can support pharmacy and medication-safety improvement programs.

Battery reliability and mobility remain operational priorities. Pumps may be transported between patient rooms, diagnostic departments, operating areas, emergency units, and procedure suites. Battery performance, charging behavior, docking infrastructure, transport durability, and visibility of battery health influence both clinical reliability and biomedical engineering workload.

The most successful innovations through 2035 will therefore be those that combine clinical reliability with measurable workflow economics. Hospitals are unlikely to pay sustained premiums for features that appear technologically sophisticated but do not reduce risk, save staff time, simplify administration, improve interoperability, or reduce ownership cost.

 

Segmentation Insights

The U.S. Large Volume Infusion Pumps Market is segmented on the basis of pump architecture, clinical application, end user, technology and connectivity, and region.

 

By Pump Architecture

Modular Multi-Channel Large Volume Infusion Systems

Modular systems represent one of the most important segments of the U.S. market because they allow multiple infusion channels to operate around a central control architecture. These systems are especially established in critical care, emergency departments, perioperative environments, and other settings where patients frequently require simultaneous infusions.

The economic advantage comes from standardization and channel density. A health system can deploy a common platform across units while configuring additional modules according to clinical acuity. Procurement decisions depend heavily on channel flexibility, bedside footprint, cable management, interoperability, reliability, and nurse familiarity.

This segment is expected to retain a substantial installed base through 2035, although competition from modern stand-alone and dual-channel systems will increase.

Stand-Alone Single-Channel LVPs

Stand-alone large volume pumps provide independent operation without requiring a central modular controller. They are particularly attractive for general medical-surgical floors, outpatient departments, smaller hospitals, and clinical environments where one or two simultaneous infusions are more common.

Their commercial appeal is increasingly linked to deployment flexibility and lower infrastructure complexity. Hospitals can redistribute independent pumps between clinical areas more easily and avoid concentrating multiple channels around one control unit. Newer systems increasingly combine stand-alone architecture with wireless drug libraries, touchscreen interfaces, analytics, and EHR connectivity.

Dual-Channel and Cassette-Based Precision Pumps

Dual-channel and cassette-based large volume pumps represent an important innovation segment. Their ability to manage primary, secondary, or concurrent therapies can improve bedside workflow where multiple compatible medications need controlled administration.

Cassette-based fluid-path designs can differentiate platforms through air-management capability, secondary-infusion handling, pumping accuracy, and troubleshooting workflow. These systems are strategically relevant in intensive care, oncology, pediatrics, and complex medical-surgical environments.

Their growth will depend on whether hospitals perceive enough workflow advantage to justify dedicated-set economics and implementation complexity.

Specialty and MRI-Compatible LVP Systems

MRI-compatible and other specialty LVP configurations represent a comparatively small market by value but serve clinically important applications. Patients requiring continuous infusions during imaging create a need for equipment compatible with controlled magnetic-resonance environments.

Purchasing is concentrated among larger hospitals, academic centers, children’s hospitals, neurology facilities, and high-acuity imaging departments. Growth will remain below mainstream smart-LVP platforms in absolute revenue but should be durable because substitution options are limited.

 

By Clinical Application

Critical Care, Sepsis and Vasoactive Infusion

Critical care is one of the highest-value applications because ICU patients frequently require multiple simultaneous infusions and high-alert medications. The approximately 1.7 million adult sepsis hospitalizations occurring annually in the U.S. reinforce demand for reliable infusion capacity involving antimicrobials, fluids, vasoactive agents, electrolytes, insulin, sedation, and other therapies.

ICU buyers place unusually high value on alarm performance, channel density, battery reliability, rapid programming, accurate low-flow performance, drug-library controls, and EHR integration. Pumps used in these environments also experience high utilization, supporting recurring administration-set consumption.

Antibiotics, Hydration and General Medical Infusion

General inpatient IV therapy represents the largest recurring-volume application. Antibiotics, hydration fluids, electrolytes, and routine medication infusions are delivered every day across medical-surgical floors, emergency departments, observation units, and specialty wards.

This segment rewards usability and cost efficiency more than specialized features. A few seconds of additional programming time multiplied across millions of annual infusions can create significant nursing burden. Health systems therefore scrutinize screen navigation, setup steps, alarm frequency, IV-set loading, transport, and battery management.

Oncology and Specialty Drug Infusion

U.S. oncology provides a substantial demand base, with more than 2 million new cancer diagnoses estimated in 2025. LVPs are used directly or indirectly across chemotherapy, hydration, antiemetics, electrolytes, antimicrobial treatment, blood products, and supportive therapy.

Academic cancer centers and hospital oncology departments generally demand strong medication libraries, highly configurable dosing safeguards, reliable event documentation, and clear pump interfaces. Outpatient oncology migration also favors equipment that can support high patient turnover and standardized infusion workflows.

Parenteral Nutrition

Parenteral nutrition requires controlled delivery of complex nutrient formulations for patients unable to meet nutritional requirements enterally. Demand is concentrated in neonatal intensive care, gastrointestinal surgery, critical illness, oncology, transplantation, and specialized nutrition programs.

Accurate delivery, compatibility with prolonged infusion times, alarm reliability, and standardized programming are essential. While total procedure volume is smaller than hydration or antibiotic therapy, parenteral nutrition represents a clinically sensitive application in which infusion reliability has high value.

Perioperative, Blood Product and Specialty Fluid Management

Operating rooms, postoperative units, trauma departments, emergency settings, and specialty procedure environments use LVPs for fluids, medications, selected blood products, and recovery-related infusions.

This application segment values mobility, rapid setup, interoperability with broader perioperative workflow, and dependable battery operation. Large surgical centers may standardize pumps with their inpatient fleet to reduce nurse retraining and biomedical maintenance complexity.

 

By End User

Acute Care Hospitals and Integrated Health Systems

Acute care hospitals dominate U.S. LVP demand and are expected to account for well over two-thirds of industry value throughout the forecast period. The scale of more than 913,000 staffed hospital beds creates an extensive installed base requiring replacement, maintenance, administration sets, software, and upgrades.

Integrated delivery networks increasingly procure infusion systems through enterprise agreements rather than hospital-by-hospital purchasing. This strengthens the importance of total cost of ownership, implementation capability, supply assurance, cybersecurity, and national service infrastructure.

Large IDNs can also exert significant negotiating power. Manufacturers must increasingly demonstrate economics over the entire contract life, including pump acquisition, software fees, dedicated-set pricing, preventative maintenance, batteries, accessories, training, integration, and replacement assumptions.

Academic Medical Centers and Tertiary Hospitals

Academic medical centers represent a smaller number of facilities but a disproportionately influential portion of premium LVP demand. These institutions manage high-acuity patients, complex surgeries, transplantation, oncology, intensive care, pediatrics, and clinical research.

They frequently act as early evaluators of new infusion technologies and may require advanced interoperability, extensive drug-library customization, analytics, cybersecurity validation, and integration with complex clinical IT environments.

Their purchasing decisions can influence wider adoption because nurses, pharmacists, biomedical engineers, and clinical leaders trained at major academic centers may carry technology preferences into other health systems.

Specialty Hospitals and Cancer Centers

Cancer hospitals, pediatric facilities, rehabilitation hospitals, cardiovascular centers, and other specialty institutions create application-specific demand. Cancer centers prioritize infusion reliability and medication-safety workflow, while pediatric facilities place strong emphasis on dosing precision and flexible drug-library configuration.

These facilities typically purchase smaller absolute fleets than national IDNs but may demonstrate a greater willingness to invest in features that address a clearly defined specialty workflow.

Ambulatory Infusion Centers and Outpatient Facilities

Hospital outpatient departments, ambulatory infusion centers, and selected surgery centers are becoming more important as U.S. healthcare shifts appropriate treatment away from traditional inpatient settings.

The key purchasing criteria differ from the ICU environment. These customers prioritize compact equipment, rapid patient turnover, low setup complexity, simple cleaning, dependable administration-set availability, and manageable ownership cost.

Growth in outpatient specialty-drug administration and oncology care supports a gradual expansion of the addressable LVP opportunity, although ambulatory and elastomeric pumps remain substitutes for therapies requiring patient mobility.

Long-Term Acute Care and Post-Acute Settings

Long-term acute care hospitals, skilled nursing environments with advanced infusion capabilities, and selected post-acute facilities form a smaller segment. Demand is driven by extended antimicrobial treatment, hydration, nutrition, and medically complex patients transitioning from acute hospitals.

Cost sensitivity is higher than at academic centers, favoring durable platforms, straightforward programming, predictable service costs, and access to refurbished or managed-equipment models.

 

By Technology and Connectivity

Smart Pumps with Dose Error Reduction Software

Smart DERS-enabled systems form the technological core of the U.S. LVP market. Hospitals use configurable medication libraries to establish institution-specific dosing and rate limits. High adoption means growth will come primarily from replacement rather than first installation.

Future differentiation will depend on library-management simplicity, clinical-area configuration, alert quality, analytics, compliance monitoring, and the ability to update fleets without significant disruption.

EHR-Interoperable and Auto-Programming Systems

EHR interoperability is expected to be one of the fastest-growing technology segments through 2035. Auto-programming reduces the need for nurses to manually reproduce medication-order information on the pump, while auto-documentation can improve data capture.

Implementation remains complex because successful interoperability requires coordination among pump manufacturers, EHR vendors, pharmacy teams, clinical engineering, networking, and hospital IT departments. Health systems willing to complete this work may gain meaningful workflow and medication-safety benefits.

Wireless Fleet and Drug-Library Management

Network-connected pumps enable centralized software deployment, drug-library updates, configuration management, status visibility, and increasingly asset-management functionality.

The value proposition rises with fleet size. A 2,000-pump health system faces fundamentally different management challenges than a 100-pump community facility. Enterprise software therefore becomes an increasingly important part of vendor differentiation as IDNs consolidate purchasing.

Infusion Analytics and Cybersecurity-Enabled Platforms

Analytics allows hospitals to evaluate alerts, overrides, programming patterns, medication-library utilization, and clinical-area performance. Rather than being an ancillary reporting tool, infusion analytics is evolving into a medication-safety management resource.

Cybersecurity capability will likewise become a prerequisite. Hospital buyers increasingly examine software-update processes, vulnerability disclosure, encryption, access controls, network segmentation compatibility, support periods, and vendor responsiveness before approving networked medical devices.

Conventional and Non-Networked Replacement Tail

A remaining population of conventional or less-connected pumps will persist, particularly in smaller hospitals, alternate care settings, backup fleets, and cost-sensitive environments.

However, this segment is expected to lose share through 2035 as hospitals standardize medication safety practices and replace aging hardware. Conventional systems will compete primarily on acquisition cost, simplicity, serviceability, and niche operating requirements rather than digital differentiation.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Large Volume Infusion Pumps Market is geographically segmented into the South, Northeast, West, and Midwest. Regional performance is determined by population size, hospital bed density, health-system consolidation, inpatient admission volumes, oncology capacity, academic medical center concentration, population growth, nursing economics, and willingness to invest in interoperable smart-infusion infrastructure.

The South is estimated to represent the largest market in 2025 at approximately USD 0.43 billion, while the West is expected to record the fastest growth through 2035. The Northeast has the greatest concentration of high-acuity academic and tertiary-care purchasing, while the Midwest remains a large, stable replacement market supported by mature hospital networks.

South

The South represents approximately USD 0.43 billion of market value in 2025 and is projected to remain the largest regional opportunity through 2035, potentially exceeding USD 1.00 billion.

The region includes Delaware, Maryland, Virginia, West Virginia, North Carolina, South Carolina, Georgia, Florida, Kentucky, Tennessee, Mississippi, Alabama, Oklahoma, Texas, Arkansas, Louisiana, and the District of Columbia under the broader U.S. Census regional framework.

Population scale is a major advantage. Texas had approximately 31.7 million residents in 2025, while Florida had approximately 23.5 million, making them the second- and third-largest states nationally. Georgia and North Carolina both exceeded 11 million residents. Population expansion is also significant: South Carolina, North Carolina, and Texas have recently ranked among faster-growing states.

Texas is expected to be the largest LVP market in the South. Houston, Dallas-Fort Worth, San Antonio, and Austin contain major academic hospitals, trauma programs, oncology networks, children’s hospitals, and expanding integrated delivery systems. Texas also combines substantial urban growth with rural referral networks, requiring both large enterprise fleets and distributed community-hospital equipment.

Florida provides a particularly attractive infusion market because of its large population, older demographic profile, oncology activity, cardiovascular burden, and extensive hospital network. Miami, Tampa, Orlando, Jacksonville, and South Florida contain major health systems with sophisticated medication-management infrastructure.

North Carolina is gaining strategic importance through population growth and strong academic and integrated provider networks. Charlotte, Raleigh-Durham, Winston-Salem, and surrounding markets support tertiary care, oncology, surgery, and biomedical innovation. Georgia displays similar momentum around Atlanta and regional health-system expansion.

Tennessee is an important healthcare operating hub, with Nashville supporting major hospital organizations and healthcare-services companies. Virginia and Maryland benefit from dense hospital markets around Washington, D.C., Baltimore, Northern Virginia, Richmond, and Hampton Roads.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, and West Virginia offer smaller absolute markets but meaningful replacement demand. Rural facility economics are more challenging in parts of these states, increasing interest in fleet standardization, reliable technical support, purchasing-group contracts, and lower lifecycle cost.

The South should remain attractive because population growth and hospital-system expansion combine with high chronic-disease and inpatient-care burden. Manufacturers able to secure enterprise contracts in Texas and Florida while developing strong regional service coverage should capture a disproportionate share of regional growth.

West

The West accounted for approximately USD 0.26 billion in 2025 and is expected to become the fastest-growing regional market, potentially reaching approximately USD 0.67 billion by 2035.

The region includes California, Washington, Oregon, Nevada, Arizona, Idaho, Montana, Wyoming, Colorado, New Mexico, Utah, Alaska, and Hawaii.

California is the dominant state. Its approximately 39.4 million residents in 2025 make it the largest U.S. state by population. California also combines academic medicine, large nonprofit and integrated health systems, substantial cancer-care infrastructure, strong health-information technology adoption, and one of the largest biomedical innovation ecosystems nationally.

Large California health systems frequently operate sophisticated procurement programs in which infusion-system selection involves pharmacy, nursing informatics, cybersecurity, biomedical engineering, IT, contracting, and quality leadership. This makes the state particularly relevant for advanced interoperability and analytics adoption.

Arizona is becoming an increasingly important market because of population growth, retirement migration, major hospital expansion, and growing tertiary care capacity around Phoenix and Tucson. Arizona was also one of the states covered in a major multiyear Ivenix procurement involving Mayo Clinic, illustrating how a single enterprise agreement can influence local installed-base dynamics.

Washington and Oregon maintain strong integrated-provider environments and generally high adoption of connected health technologies. Seattle and Portland support sophisticated hospital systems capable of adopting EHR-integrated infusion platforms.

Colorado and Utah are attractive growth markets because of expanding metropolitan populations and strong integrated delivery networks. Utah’s younger population changes the clinical mix relative to Florida or Arizona, but population growth and hospital expansion continue to support equipment demand.

Nevada and Idaho are comparatively smaller but expanding rapidly enough to require new inpatient capacity and modernized hospital infrastructure. Montana, Wyoming, New Mexico, Alaska, and Hawaii have lower absolute market sizes but create distinct opportunities around rural referral systems, equipment reliability, remote service coverage, and fleet standardization.

The West is expected to gain market share because purchasing is increasingly influenced by interoperability, software architecture, data analytics, and clinical workflow—all areas where major Western provider systems tend to evaluate new technology aggressively.

Northeast

The Northeast represented approximately USD 0.28 billion in 2025 and could reach approximately USD 0.63 billion by 2035.

The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Vermont, New Hampshire, and Maine.

New York is the dominant state market, supported by approximately 20.0 million residents, dense metropolitan hospital networks, major academic systems, large oncology programs, and complex tertiary-care delivery. The New York City region alone represents one of the most concentrated hospital equipment markets in the country.

Pennsylvania has approximately 13.1 million residents and offers large hospital markets around Philadelphia, Pittsburgh, Hershey, and other regional centers. Its combination of academic centers and community systems creates demand for both premium connected platforms and cost-focused fleet replacement.

New Jersey has approximately 9.5 million residents and one of the highest population densities in the U.S. Its proximity to New York and Philadelphia, significant pharmaceutical industry presence, and substantial hospital infrastructure make it an attractive infusion-technology market.

Massachusetts exerts influence beyond its approximately 7.2 million residents because Boston is one of the most concentrated academic medical ecosystems globally. Major teaching hospitals frequently act as technology evaluators, clinical research partners, and early adopters.

Connecticut, Rhode Island, New Hampshire, Maine, and Vermont are smaller but relatively mature healthcare markets. Procurement is frequently driven by health-system consolidation, aging equipment, standardization across acquired hospitals, and pressure to support high medication-safety standards with limited clinical labor.

The Northeast is unlikely to lead national growth by population expansion, but it remains particularly attractive for premium smart-infusion platforms because of its high hospital acuity, specialist concentration, sophisticated IT infrastructure, and rigorous medication-safety governance.

Midwest

The Midwest represented approximately USD 0.21 billion in 2025 and is projected to approach approximately USD 0.43–0.44 billion by 2035.

The region includes Illinois, Indiana, Michigan, Ohio, Wisconsin, Minnesota, Iowa, Missouri, Kansas, Nebraska, North Dakota, and South Dakota.

Illinois, Ohio, Michigan, and Minnesota are the principal state markets. Illinois had approximately 12.7 million residents in 2025, with Chicago providing a major academic, community-hospital, oncology, and tertiary-care cluster.

Ohio, with approximately 11.9 million residents, has an unusually strong concentration of large health systems and internationally recognized tertiary institutions. Enterprise fleet replacements in Ohio can be substantial because major providers operate multiple hospitals across broad geographic footprints.

Michigan provides a large installed base centered around Detroit, Ann Arbor, Grand Rapids, and other regional markets. Its mix of academic institutions and community networks creates recurring replacement demand.

Minnesota is strategically significant because it combines major integrated provider organizations with a longstanding medical technology ecosystem. Mayo Clinic’s multiyear agreement covering thousands of Ivenix large volume pumps across Minnesota, Arizona, and Florida demonstrates how a single enterprise decision can create significant multi-state market impact.

Wisconsin, Indiana, and Missouri provide stable hospital demand supported by large health systems and mature inpatient infrastructure. Iowa, Kansas, Nebraska, North Dakota, and South Dakota are smaller state markets where procurement increasingly emphasizes service reliability, standardization, and the ability to support geographically distributed facilities.

The Midwest is unlikely to grow as rapidly as the West or South but should remain one of the most dependable markets for replacement programs. Manufacturers that provide strong field service, biomedical support, administration-set economics, and enterprise contracting should retain an advantage.

 

Key Market Players

The U.S. Large Volume Infusion Pumps competitive landscape is considerably more concentrated than the broader infusion-device market. A limited group of manufacturers controls the majority of acute-care LVP platform opportunities because entry requires FDA-cleared hardware, dedicated consumables, medication-safety software, hospital interoperability, national field service, clinical implementation capability, and the ability to support large installed fleets for many years.

The most important direct platform competitors are Becton, Dickinson and Company (BD), Baxter International, ICU Medical, Fresenius Kabi, B. Braun Medical, and Zyno Medical.

The broader competitive ecosystem also includes companies influencing infusion delivery, equipment lifecycle management, distribution, interoperability, or adjacent infusion technology. Relevant participants include InfuSystem Holdings, Agiliti, Eitan Medical, Moog Medical, Terumo Americas, Avanos Medical, Nipro Medical, Cardinal Health, Medline Industries, McKesson Corporation, Owens & Minor, GE HealthCare, Philips, Epic Systems, Oracle Health, Nihon Kohden America, and Siemens Healthineers.

BD remains one of the most strategically important competitors because of the installed base and ecosystem surrounding the Alaris platform. Following FDA clearance of an updated Alaris system in 2023, BD began the process of remediating and replacing affected U.S. devices, creating an important installed-base defense and modernization cycle.

Baxter strengthened competition when its Novum IQ Large Volume Pump with Dose IQ Safety Software received U.S. FDA clearance in 2024. Novum IQ gives Baxter a newer smart-pump platform with shared large-volume and syringe-pump architecture and connectivity capabilities.

ICU Medical competes through its established Plum technology and newer precision-infusion roadmap. Plum Duo and Plum Solo expand its options for facilities evaluating contemporary single- and dual-channel architectures. The company also has an important strategic advantage through its broader infusion systems, IV sets, consumables, and medication-delivery portfolio.

Fresenius Kabi has established Ivenix as a credible challenger to legacy LVP platforms. The multiyear Mayo Clinic agreement for an expected 10,000 Ivenix pumps across Minnesota, Arizona, and Florida demonstrated the platform’s ability to compete for large enterprise conversions.

B. Braun remains relevant through its Infusomat Space and broader infusion therapy portfolio. Its competitive strengths include infusion hardware, administration products, pharmacy-related expertise, and experience serving large hospital systems.

Competition through 2035 will increasingly revolve around conversion economics. Once a health system selects an LVP platform, switching can require new administration sets, new nurse training, new drug-library configuration, EHR interface redevelopment, biomedical procedures, cybersecurity validation, and extensive go-live support. Winning a major account therefore creates both multi-year revenue visibility and a substantial defensive barrier.

At the same time, this stickiness raises the stakes of quality events. Software anomalies, recalls, battery problems, alarm behavior, set-related issues, or cybersecurity weaknesses can affect not only individual pump revenue but confidence in an entire enterprise platform.

 

Recent Developments

Recent developments in the U.S. Large Volume Infusion Pumps Market indicate that the competitive landscape has entered one of its most significant technology-reset periods in years.

In July 2023, BD received FDA 510(k) clearance for an updated BD Alaris Infusion System. The clearance included updated hardware and software covering the point-of-care unit, large volume pumps, syringe pumps, PCA pumps, interoperability functionality, cybersecurity enhancements, and related system components. Strategically, the clearance enabled BD to progress with U.S. remediation and return toward normal commercial activity for one of the largest installed infusion platforms in the country.

In August 2023, ICU Medical announced FDA clearance of the Plum Duo infusion pump with LifeShield infusion safety software, introducing a newer dual-channel architecture into the U.S. market. ICU Medical subsequently expanded the Plum precision pump strategy, including support for Plum Solo, reinforcing the company’s long-term effort to modernize its large-volume infusion franchise.

In December 2023, Fresenius Kabi announced a multiyear supply and service agreement under which Mayo Clinic was expected to purchase 10,000 Ivenix large volume infusion pumps for hospitals and clinics in Minnesota, Arizona, and Florida. The agreement is strategically important because it demonstrates the scale at which major U.S. integrated health systems can undertake enterprise infusion-platform conversions.

In April 2024, Baxter announced FDA clearance of the Novum IQ Large Volume Infusion Pump with Dose IQ Safety Software. The platform expanded Baxter’s Novum IQ architecture by adding a large-volume modality alongside its syringe pump and digital connectivity capabilities.

During 2025, ICU Medical continued expansion of the Plum precision platform, while hospital buyers increasingly evaluated newer systems against remediated legacy fleets. The existence of multiple contemporary alternatives is expected to increase competitive procurement activity as existing hospital contracts reach renewal and equipment fleets age.

Safety and quality remain highly visible competitive variables. FDA communications during 2025 and 2026 addressed corrections involving Novum IQ large volume pumps and Ivenix large volume infusion systems. Such events reinforce an important market reality: infusion pumps are safety-critical systems, and lifecycle quality management can materially affect procurement decisions.

The competitive implications extend beyond the individual correction. Hospital buyers now examine a manufacturer’s software quality system, field-correction speed, communication processes, supply continuity, service responsiveness, cybersecurity capabilities, and long-term support strategy before making large capital commitments.

The market is therefore evolving simultaneously in two directions: greater technological sophistication and greater scrutiny. Companies introducing advanced software features must demonstrate that increased connectivity does not introduce unacceptable reliability or cybersecurity complexity.

 

Conclusion

The U.S. Large Volume Infusion Pumps Market Size & Share is positioned for substantial expansion from approximately USD 1.18 billion in 2025 to USD 2.74 billion by 2035, representing a CAGR of approximately 8.8% during 2026–2035.

The market’s underlying strength comes from the indispensable role of controlled IV medication delivery across more than 900,000 staffed hospital beds and more than 34 million annual hospital admissions. However, the next decade of revenue growth will not simply reflect more pumps being placed at bedsides.

Value creation is shifting toward replacement of aging fleets, smart-pump modernization, EHR interoperability, dose error reduction software, cybersecurity, infusion analytics, improved nurse interfaces, wireless fleet management, and recurring administration-set revenue.

Acute care hospitals and integrated delivery networks will continue to dominate purchasing. Their procurement decisions will increasingly be made through multidisciplinary value-analysis processes involving nursing, pharmacy, clinical engineering, information technology, cybersecurity, supply chain, finance, and medication-safety teams.

The South will remain the largest regional market, supported particularly by Texas, Florida, North Carolina, Georgia, Tennessee, Virginia, and other growing hospital markets. The West is expected to record the fastest expansion, led by California and supported by Arizona, Washington, Colorado, Utah, Nevada, and other population-growth markets. The Northeast will remain disproportionately important for premium technology adoption, while the Midwest will provide a durable installed-base replacement opportunity.

At the company level, BD, Baxter, ICU Medical, Fresenius Kabi, and B. Braun will remain the central competitors. The competitive balance is nevertheless more open than it has been historically because several manufacturers now have contemporary U.S. platforms capable of competing for large enterprise conversions.

For manufacturers, the most important commercial objective will be winning the next generation of health-system standardization decisions. A major infusion fleet contract can create years of pump, administration-set, software, service, and accessory revenue.

For hospitals, the central purchasing question will increasingly be whether a platform improves the total economics and safety of medication administration, not whether its initial pump acquisition cost is lowest.

For investors and strategic decision-makers, the most attractive portion of the market lies at the intersection of medical-device replacement and digital hospital infrastructure. The large volume infusion pump is becoming a connected medication-management endpoint, and vendors capable of combining clinically dependable hardware, intuitive nursing workflow, interoperability, recurring consumables, cybersecurity, and enterprise service will be best positioned to capture the U.S. market opportunity through 2035.

 

TABLE OF CONTENT

1. U.S. Large Volume Infusion Pumps Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Market Forecasting Models
1.3.6. Data Triangulation, Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Large Volume Infusion Pump Manufacturers
1.6.2. Pump Components, Electronics and Contract Manufacturing Suppliers
1.6.3. IV Administration Set and Infusion Consumables Suppliers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Academic Medical Centers, Cancer Centers and Specialty Hospitals
1.6.6. Ambulatory Infusion Centers and Alternate Care Providers
1.6.7. Group Purchasing Organizations, Distributors and Equipment Management Providers
1.6.8. Pharmacy, Nursing, Biomedical Engineering and Clinical Informatics Stakeholders
1.6.9. EHR, Interoperability and Healthcare IT Vendors
1.6.10. FDA, CMS, Accreditation Bodies and Medication-Safety Stakeholders

What this section provides: This section defines the U.S. large volume infusion pumps market boundary, research scope, methodology, assumptions, revenue inclusion criteria, and stakeholder ecosystem so clients understand how pump hardware, dedicated consumables, software, connectivity, service and associated recurring revenue are measured and validated.

2. U.S. Large Volume Infusion Pumps Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. U.S. Installed-Base and Replacement-Cycle Outlook
2.8. High-Growth Opportunity Areas
2.9. Key Hospital Procurement Priorities
2.10. Critical Success Factors for Infusion Platform Vendors

What this section provides: This section gives decision-makers a concise view of market size, historical performance, forecast growth, installed-base replacement, competitive intensity, hospital purchasing priorities, and the most attractive commercial opportunities through 2035.

3. U.S. Large Volume Infusion Pumps Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. High Volume of Hospital-Based Intravenous Therapy
3.1.2. Replacement of Aging Large Volume Infusion Pump Fleets
3.1.3. Growing Adoption of Smart Pumps and Dose Error Reduction Software
3.1.4. Expansion of EHR-Integrated and Auto-Programming Infusion Workflows
3.1.5. Rising Medication-Safety and High-Alert Drug Management Requirements
3.1.6. Nursing Workforce Constraints and Demand for Workflow Efficiency
3.1.7. Growth in Critical Care, Sepsis, Oncology and Specialty Infusion Demand
3.1.8. Recurring Revenue from Dedicated Administration Sets and Accessories

3.2. Restraints and Their Impact Analysis
3.2.1. High Enterprise Fleet Replacement and Implementation Costs
3.2.2. Long Hospital Procurement and Validation Cycles
3.2.3. Product Recalls, Software Defects and Safety Concerns
3.2.4. Cybersecurity and Network Integration Complexity
3.2.5. High Switching Costs Associated with Dedicated Administration Sets
3.2.6. Hospital Capital Budget and Operating Margin Pressure

3.3. Opportunities and Their Impact Analysis
3.3.1. Replacement of Legacy Smart Infusion Pump Installations
3.3.2. Bidirectional EHR Interoperability and Auto-Documentation
3.3.3. Wireless Fleet Management and Centralized Drug-Library Administration
3.3.4. Infusion Analytics and Medication-Safety Intelligence
3.3.5. Expansion of Oncology and Ambulatory Infusion Infrastructure
3.3.6. Managed Equipment, Service and Lifecycle Support Models
3.3.7. Enterprise IDN Standardization Opportunities

3.4. Challenges and Their Impact Analysis
3.4.1. Nurse Training and Change Management Requirements
3.4.2. Maintaining Drug-Library Compliance Across Large Fleets
3.4.3. Alarm Burden and User-Interface Complexity
3.4.4. IV Administration Set Supply Continuity
3.4.5. Biomedical Engineering Service and Maintenance Burden
3.4.6. Competitive Pricing Pressure During Enterprise Conversions

3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Hospital Capital Procurement Behavior Analysis
3.8. Infusion Fleet Replacement-Cycle Analysis
3.9. Dedicated Administration Set Economics Analysis
3.10. Smart Pump Interoperability Adoption Analysis

What this section provides: This section explains the clinical, operational, technological and economic forces shaping demand and provides clients with an assessment of market upside, adoption barriers, replacement timing, infusion workflow economics and execution risks.

4. U.S. Large Volume Infusion Pumps Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal

4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Hospital and IDN Buyers
4.2.3. Bargaining Power of Component and Consumable Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry

4.3. Large Volume Infusion Pump Pricing Trend Analysis by Region, 2025–2035
4.4. Administration Set and Recurring Consumable Pricing Analysis
4.5. Value Chain & Supply Chain Analysis
4.6. U.S. Infusion Pump Installed-Base and Replacement Landscape
4.7. Impact of Digitalization and Connected Medication Administration
4.8. Smart Pump Interoperability and EHR Integration Landscape
4.9. Application & Innovation Landscape
4.10. FDA Regulatory Framework Analysis
4.11. FDA Infusion Pump Recall, Correction and Safety Landscape
4.12. CMS Payment and Reimbursement Environment
4.13. Medical Device Cybersecurity Regulatory Landscape
4.14. Import/Export Restrictions & Tariff Impact
4.15. Government Medication-Safety and Healthcare Digitalization Initiatives
4.16. Impact of Escalating Geopolitical and Supply Chain Tensions
4.17. Hospital Value Analysis Committee Decision Framework
4.18. Enterprise Infusion Pump RFP and Vendor Selection Framework

What this section provides: This section gives clients a complete view of the external market environment, including regulation, safety, pricing, reimbursement, cybersecurity, supply chain, digital integration, purchasing structures and value-analysis criteria influencing U.S. infusion platform adoption.

5. U.S. Large Volume Infusion Pumps Market – By Pump Architecture

5.1. Overview
5.1.1. Segment Share Analysis, By Pump Architecture, 2025 & 2035 (%)
5.1.2. Modular Multi-Channel Large Volume Infusion Systems
5.1.3. Stand-Alone Single-Channel Large Volume Infusion Pumps
5.1.4. Dual-Channel Large Volume Infusion Pumps
5.1.5. Cassette-Based Precision Large Volume Infusion Pumps
5.1.6. Specialty and MRI-Compatible Large Volume Infusion Pumps

What this section provides: This section identifies how different large volume infusion pump architectures compete across U.S. clinical settings and evaluates their revenue contribution, replacement potential, workflow advantages and growth prospects through 2035.

6. U.S. Large Volume Infusion Pumps Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Critical Care, Sepsis and Vasoactive Drug Infusion
6.1.3. Antibiotics, Hydration and General Medical Infusion
6.1.4. Oncology and Specialty Drug Infusion
6.1.5. Parenteral Nutrition
6.1.6. Perioperative and Postoperative Infusion
6.1.7. Blood Products and Specialty Fluid Management

What this section provides: This section measures LVP demand by major clinical use case and helps clients identify applications offering high infusion frequency, strong smart-pump requirements, recurring administration-set demand and attractive replacement opportunities.

7. U.S. Large Volume Infusion Pumps Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Acute Care Hospitals and Integrated Health Systems
7.1.3. Academic Medical Centers and Tertiary Care Hospitals
7.1.4. Specialty Hospitals and Cancer Centers
7.1.5. Ambulatory Infusion Centers and Hospital Outpatient Departments
7.1.6. Long-Term Acute Care Hospitals and Post-Acute Care Settings

What this section provides: This section identifies the customer groups driving pump purchases, enterprise fleet conversions, administration-set consumption, interoperability deployment and recurring lifecycle service demand.

8. U.S. Large Volume Infusion Pumps Market – By Technology & Connectivity

8.1. Overview
8.1.1. Segment Share Analysis, By Technology & Connectivity, 2025 & 2035 (%)
8.1.2. Smart Pumps with Dose Error Reduction Software
8.1.3. EHR-Interoperable and Auto-Programming Infusion Pumps
8.1.4. Wireless Fleet and Drug-Library Management Systems
8.1.5. Infusion Analytics and Medication-Safety Platforms
8.1.6. Cybersecurity-Enabled Connected Infusion Platforms
8.1.7. Conventional and Non-Networked Large Volume Infusion Pumps

What this section provides: This section evaluates the technologies transforming large-volume infusion from standalone fluid delivery into connected medication-management infrastructure and identifies where interoperability, analytics, cybersecurity and software are creating premium value.

9. U.S. Large Volume Infusion Pumps Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.4. Group Purchasing Organization Contracts
9.1.5. Distributor and Specialty Medical Supplier Sales
9.1.6. Equipment Leasing, Rental and Managed Fleet Models
9.1.7. Ambulatory and Alternate-Site Procurement

What this section provides: This section explains how U.S. large volume infusion pumps and related consumables are purchased, with emphasis on enterprise RFPs, IDN standardization, GPO contracting, distributor participation, leasing models and alternate-site procurement.

10. U.S. Large Volume Infusion Pumps Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Hospital Bed, Admission and IV Therapy Demand Analysis
10.1.4. Regional Infusion Pump Installed-Base and Replacement-Cycle Analysis
10.1.5. Regional Smart Pump and EHR Interoperability Adoption Analysis
10.1.6. Regional Procurement, IDN Consolidation and GPO Dynamics

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Large Volume Infusion Pump Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Large Volume Infusion Pump Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware

10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Large Volume Infusion Pump Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Large Volume Infusion Pump Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Pump Architecture, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers granular four-region and 50-state analysis, enabling clients to identify priority hospital markets, infusion-pump replacement hotspots, high-volume IV therapy states, smart-pump interoperability opportunities, IDN concentration and state-level commercial potential.

11. U.S. Large Volume Infusion Pumps Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Intensity and Installed-Base Analysis
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging and Niche Players

11.4. Competitive Benchmarking
11.4.1. Pump Architecture and Channel Capability
11.4.2. Dose Error Reduction Software Capability
11.4.3. EHR Interoperability and Auto-Programming Capability
11.4.4. Infusion Analytics and Fleet Management Capability
11.4.5. Administration Set Portfolio and Recurring Revenue Position
11.4.6. Cybersecurity and Software Lifecycle Support
11.4.7. U.S. Service and Clinical Implementation Capability

11.5. Company Profiles

11.5.1. Becton, Dickinson and Company (BD)
11.5.2. Baxter International Inc.
11.5.3. ICU Medical, Inc.
11.5.4. Fresenius Kabi
11.5.5. B. Braun Medical Inc.
11.5.6. Zyno Medical LLC
11.5.7. Eitan Medical
11.5.8. Moog Medical
11.5.9. Terumo Medical Corporation
11.5.10. Nipro Medical Corporation
11.5.11. Cardinal Health, Inc.
11.5.12. Medline Industries, LP
11.5.13. McKesson Corporation
11.5.14. Owens & Minor, Inc.
11.5.15. Agiliti, Inc.
11.5.16. InfuSystem Holdings, Inc.
11.5.17. Epic Systems Corporation
11.5.18. Oracle Health
11.5.19. GE HealthCare Technologies Inc.
11.5.20. Koninklijke Philips N.V.
11.5.21. Siemens Healthineers AG
11.5.22. Nihon Kohden America, Inc.
11.5.23. Avanos Medical, Inc.
11.5.24. Mindray North America
11.5.25. Masimo Corporation

Note: Each company profile will include company overview, U.S. infusion or adjacent medication-delivery portfolio, large volume pump platform positioning where applicable, installed-base strategy, administration-set and recurring revenue exposure, interoperability capabilities, U.S. commercial strategy, FDA/regulatory developments, hospital partnerships, product launches, recalls/corrections where relevant, and recent strategic developments.

What this section provides: This section gives clients market-share visibility, installed-base intelligence, platform benchmarking, technology differentiation, recurring consumable exposure and strategic analysis of direct LVP manufacturers and other important participants in the U.S. infusion ecosystem.

12. U.S. Large Volume Infusion Pumps Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario

12.2. Disruptive Technologies Impact
12.2.1. Bidirectional EHR Interoperability and Closed-Loop Medication Administration
12.2.2. AI-Assisted Infusion Analytics and Medication-Safety Intelligence
12.2.3. Next-Generation Pump User Interfaces and Human-Factors Engineering
12.2.4. Advanced Wireless Fleet Management and Predictive Maintenance
12.2.5. Cybersecurity-by-Design Infusion Platforms
12.2.6. Next-Generation Cassette and Fluid-Delivery Technologies

12.3. Evolution of Large Volume Pump Architecture
12.4. U.S. Smart Pump Replacement Wave Outlook
12.5. Administration Set and Consumable Revenue Outlook
12.6. Emerging Business Models and Managed Equipment Services
12.7. Business Opportunities for Existing Players and New Entrants
12.8. Investment Prioritization Matrix
12.9. Technology Adoption Roadmap, 2026–2035

What this section provides: This section prepares clients for future infusion technology shifts, replacement-cycle timing, market structure changes, software-led differentiation, new business models and investment opportunities through 2035.

13. U.S. Large Volume Infusion Pumps Market: Strategic Recommendations

13.1. Recommendations for Large Volume Infusion Pump Manufacturers
13.2. Recommendations for Hospitals and Integrated Delivery Networks
13.3. Recommendations for Pharmacy and Medication-Safety Leaders
13.4. Recommendations for Biomedical Engineering and Clinical Informatics Teams
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors, GPOs and Equipment Service Providers
13.7. Recommendations for New Entrants and Technology Startups
13.8. U.S. Go-to-Market Strategy Considerations
13.9. Enterprise Hospital Contracting Strategy
13.10. Product Positioning and Portfolio Expansion Guidance
13.11. Administration Set and Recurring Revenue Strategy
13.12. Smart Pump Interoperability Commercialization Strategy
13.13. Hospital Conversion and Competitive Displacement Strategy

What this section provides: This section translates market intelligence into actionable recommendations for growth planning, enterprise account conversion, product positioning, consumables strategy, interoperability investment, channel development and competitive differentiation.

14. U.S. Large Volume Infusion Pumps Market: Disclaimer

14.1. Scope Limitation
14.2. Market Definition and Revenue Inclusion Limitation
14.3. Data Use Limitation
14.4. Forecasting Limitation
14.5. State-Level Market Estimation Limitation
14.6. Company and Competitive Intelligence Limitation
14.7. Legal Disclaimer
14.8. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s research boundaries, market-sizing assumptions, state-level estimation limitations, forecast uncertainty, company-data limitations, legal conditions and permitted use of the market intelligence.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Large Volume Infusion Pumps Market: Market Definition and Scope
TABLE 3: U.S. Large Volume Infusion Pumps Market: Research Methodology Framework
TABLE 4: U.S. Large Volume Infusion Pumps Market: Key Assumptions
TABLE 5: U.S. Large Volume Infusion Pumps Market: Market Ecosystem Overview
TABLE 6: U.S. Large Volume Infusion Pumps Market: Stakeholder Analysis
TABLE 7: U.S. Large Volume Infusion Pumps Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Large Volume Infusion Pumps Market: Analyst Viewpoint Summary
TABLE 9: U.S. Large Volume Infusion Pumps Market: Market Attractiveness Index
TABLE 10: U.S. Large Volume Infusion Pumps Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Large Volume Infusion Pumps Market: Base Year Market Positioning, 2025
TABLE 12: U.S. Large Volume Infusion Pumps Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Large Volume Infusion Pumps Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 14: U.S. Large Volume Infusion Pumps Market: Installed-Base, Replacement Cycle and High-Growth Opportunity Snapshot
TABLE 15: U.S. Large Volume Infusion Pumps Market: Drivers; Impact Analysis
TABLE 16: U.S. Large Volume Infusion Pumps Market: Restraints; Impact Analysis
TABLE 17: U.S. Large Volume Infusion Pumps Market: Opportunities; Impact Analysis
TABLE 18: U.S. Large Volume Infusion Pumps Market: Challenges; Impact Analysis
TABLE 19: U.S. Large Volume Infusion Pumps Market: Patent & Innovation Analysis, 2021–2025
TABLE 20: U.S. Large Volume Infusion Pumps Market: Clinical Workflow Economics Matrix
TABLE 21: U.S. Large Volume Infusion Pumps Market: Hospital Capital Procurement Behavior Matrix
TABLE 22: U.S. Large Volume Infusion Pumps Market: Infusion Fleet Replacement-Cycle Analysis
TABLE 23: U.S. Large Volume Infusion Pumps Market: Dedicated Administration Set Economics Analysis
TABLE 24: U.S. Large Volume Infusion Pumps Market: Smart Pump Interoperability Adoption Analysis
TABLE 25: U.S. Large Volume Infusion Pumps Market: PESTEL Analysis
TABLE 26: U.S. Large Volume Infusion Pumps Market: Porter’s Five Forces Analysis
TABLE 27: U.S. Large Volume Infusion Pumps Market: Large Volume Infusion Pump Pricing Trend Analysis by Region, 2025–2035
TABLE 28: U.S. Large Volume Infusion Pumps Market: Administration Set and Recurring Consumable Pricing Analysis
TABLE 29: U.S. Large Volume Infusion Pumps Market: Value Chain Analysis
TABLE 30: U.S. Large Volume Infusion Pumps Market: Supply Chain Analysis
TABLE 31: U.S. Large Volume Infusion Pumps Market: Installed-Base and Replacement Landscape
TABLE 32: U.S. Large Volume Infusion Pumps Market: Digitalization and Connected Medication Administration Impact
TABLE 33: U.S. Large Volume Infusion Pumps Market: Smart Pump Interoperability and EHR Integration Landscape
TABLE 34: U.S. Large Volume Infusion Pumps Market: Application & Innovation Landscape
TABLE 35: U.S. Large Volume Infusion Pumps Market: FDA Regulatory Framework Analysis
TABLE 36: U.S. Large Volume Infusion Pumps Market: FDA Recall, Correction and Safety Landscape
TABLE 37: U.S. Large Volume Infusion Pumps Market: CMS Payment and Reimbursement Environment
TABLE 38: U.S. Large Volume Infusion Pumps Market: Medical Device Cybersecurity Regulatory Landscape
TABLE 39: U.S. Large Volume Infusion Pumps Market: Import/Export Restrictions & Tariff Impact
TABLE 40: U.S. Large Volume Infusion Pumps Market: Government Medication-Safety and Digitalization Initiatives
TABLE 41: U.S. Large Volume Infusion Pumps Market: Impact of Geopolitical and Supply Chain Tensions
TABLE 42: U.S. Large Volume Infusion Pumps Market: Hospital Value Analysis Committee Decision Framework
TABLE 43: U.S. Large Volume Infusion Pumps Market: Enterprise Infusion Pump RFP and Vendor Selection Framework
TABLE 44: U.S. Large Volume Infusion Pumps Market: Pump Architecture Snapshot, 2025
TABLE 45: Segment Dashboard; Definition and Scope, by Pump Architecture
TABLE 46: U.S. Large Volume Infusion Pumps Market, by Pump Architecture, 2021–2035 (US$ Billion)
TABLE 47: U.S. Large Volume Infusion Pumps Market: Segment Share Analysis, by Pump Architecture, 2025 & 2035 (%)
TABLE 48: U.S. Large Volume Infusion Pumps Market: Modular Multi-Channel Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Large Volume Infusion Pumps Market: Stand-Alone Single-Channel Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Large Volume Infusion Pumps Market: Dual-Channel Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Large Volume Infusion Pumps Market: Cassette-Based Precision Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Large Volume Infusion Pumps Market: Specialty and MRI-Compatible Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Large Volume Infusion Pumps Market: Application Snapshot, 2025
TABLE 54: Segment Dashboard; Definition and Scope, by Application
TABLE 55: U.S. Large Volume Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 56: U.S. Large Volume Infusion Pumps Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 57: U.S. Large Volume Infusion Pumps Market: Critical Care, Sepsis and Vasoactive Drug Infusion Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Large Volume Infusion Pumps Market: Antibiotics, Hydration and General Medical Infusion Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Large Volume Infusion Pumps Market: Oncology and Specialty Drug Infusion Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Large Volume Infusion Pumps Market: Parenteral Nutrition Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Large Volume Infusion Pumps Market: Perioperative and Postoperative Infusion Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Large Volume Infusion Pumps Market: Blood Products and Specialty Fluid Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Large Volume Infusion Pumps Market: End User Snapshot, 2025
TABLE 64: Segment Dashboard; Definition and Scope, by End User
TABLE 65: U.S. Large Volume Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 66: U.S. Large Volume Infusion Pumps Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 67: U.S. Large Volume Infusion Pumps Market: Acute Care Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Large Volume Infusion Pumps Market: Academic Medical Centers and Tertiary Care Hospitals Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Large Volume Infusion Pumps Market: Specialty Hospitals and Cancer Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: U.S. Large Volume Infusion Pumps Market: Ambulatory Infusion Centers and Hospital Outpatient Departments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Large Volume Infusion Pumps Market: Long-Term Acute Care Hospitals and Post-Acute Care Settings Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Large Volume Infusion Pumps Market: Technology & Connectivity Snapshot, 2025
TABLE 73: Segment Dashboard; Definition and Scope, by Technology & Connectivity
TABLE 74: U.S. Large Volume Infusion Pumps Market, by Technology & Connectivity, 2021–2035 (US$ Billion)
TABLE 75: U.S. Large Volume Infusion Pumps Market: Segment Share Analysis, by Technology & Connectivity, 2025 & 2035 (%)
TABLE 76: U.S. Large Volume Infusion Pumps Market: Smart Pumps with Dose Error Reduction Software Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Large Volume Infusion Pumps Market: EHR-Interoperable and Auto-Programming Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Large Volume Infusion Pumps Market: Wireless Fleet and Drug-Library Management Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: U.S. Large Volume Infusion Pumps Market: Infusion Analytics and Medication-Safety Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: U.S. Large Volume Infusion Pumps Market: Cybersecurity-Enabled Connected Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Large Volume Infusion Pumps Market: Conventional and Non-Networked Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Large Volume Infusion Pumps Market: Procurement Channel Snapshot, 2025
TABLE 83: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 84: U.S. Large Volume Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 85: U.S. Large Volume Infusion Pumps Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 86: U.S. Large Volume Infusion Pumps Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: U.S. Large Volume Infusion Pumps Market: IDN Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 88: U.S. Large Volume Infusion Pumps Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 89: U.S. Large Volume Infusion Pumps Market: Distributor and Specialty Medical Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 90: U.S. Large Volume Infusion Pumps Market: Equipment Leasing, Rental and Managed Fleet Models Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 91: U.S. Large Volume Infusion Pumps Market: Ambulatory and Alternate-Site Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 92: U.S. Large Volume Infusion Pumps Market: Regional Snapshot, 2025
TABLE 93: Segment Dashboard; Definition and Scope, by Region
TABLE 94: U.S. Large Volume Infusion Pumps Market, by Region, 2021–2035 (US$ Billion)
TABLE 95: U.S. Large Volume Infusion Pumps Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 96: West Region U.S. Large Volume Infusion Pumps Market: Regional Overview and Trends
TABLE 97: West Region U.S. Large Volume Infusion Pumps Market: Key Manufacturers and Procurement Ecosystem
TABLE 98: West Region U.S. Large Volume Infusion Pumps Market, by State, 2021–2035 (US$ Billion)
TABLE 99: West Region U.S. Large Volume Infusion Pumps Market, by Pump Architecture, 2021–2035 (US$ Billion)
TABLE 100: West Region U.S. Large Volume Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 101: West Region U.S. Large Volume Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 102: West Region U.S. Large Volume Infusion Pumps Market, by Technology & Connectivity, 2021–2035 (US$ Billion)
TABLE 103: West Region U.S. Large Volume Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 104: California Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 105: Washington Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 106: Arizona Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 107: Colorado Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 108: Oregon Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 109: Utah Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 110: Nevada Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 111: New Mexico Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 112: Idaho Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 113: Montana Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 114: Wyoming Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 115: Alaska Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 116: Hawaii Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 117: Northeast Region U.S. Large Volume Infusion Pumps Market: Regional Overview and Trends
TABLE 118: Northeast Region U.S. Large Volume Infusion Pumps Market: Key Manufacturers and Procurement Ecosystem
TABLE 119: Northeast Region U.S. Large Volume Infusion Pumps Market, by State, 2021–2035 (US$ Billion)
TABLE 120: Northeast Region U.S. Large Volume Infusion Pumps Market, by Pump Architecture, 2021–2035 (US$ Billion)
TABLE 121: Northeast Region U.S. Large Volume Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 122: Northeast Region U.S. Large Volume Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 123: Northeast Region U.S. Large Volume Infusion Pumps Market, by Technology & Connectivity, 2021–2035 (US$ Billion)
TABLE 124: Northeast Region U.S. Large Volume Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 125: New York Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 126: Massachusetts Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 127: New Jersey Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 128: Pennsylvania Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 129: Connecticut Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 130: Maine Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 131: Vermont Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 132: New Hampshire Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 133: Rhode Island Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 134: Delaware Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 135: South Region U.S. Large Volume Infusion Pumps Market: Regional Overview and Trends
TABLE 136: South Region U.S. Large Volume Infusion Pumps Market: Key Manufacturers and Procurement Ecosystem
TABLE 137: South Region U.S. Large Volume Infusion Pumps Market, by State, 2021–2035 (US$ Billion)
TABLE 138: South Region U.S. Large Volume Infusion Pumps Market, by Pump Architecture, 2021–2035 (US$ Billion)
TABLE 139: South Region U.S. Large Volume Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 140: South Region U.S. Large Volume Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 141: South Region U.S. Large Volume Infusion Pumps Market, by Technology & Connectivity, 2021–2035 (US$ Billion)
TABLE 142: South Region U.S. Large Volume Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 143: Texas Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 144: Florida Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 145: Georgia Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 146: North Carolina Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 147: Tennessee Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 148: South Carolina Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 149: Alabama Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 150: Mississippi Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 151: Louisiana Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 152: Arkansas Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 153: Kentucky Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 154: Oklahoma Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 155: Virginia Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 156: Maryland Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 157: West Virginia Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 158: Midwest Region U.S. Large Volume Infusion Pumps Market: Regional Overview and Trends
TABLE 159: Midwest Region U.S. Large Volume Infusion Pumps Market: Key Manufacturers and Procurement Ecosystem
TABLE 160: Midwest Region U.S. Large Volume Infusion Pumps Market, by State, 2021–2035 (US$ Billion)
TABLE 161: Midwest Region U.S. Large Volume Infusion Pumps Market, by Pump Architecture, 2021–2035 (US$ Billion)
TABLE 162: Midwest Region U.S. Large Volume Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 163: Midwest Region U.S. Large Volume Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 164: Midwest Region U.S. Large Volume Infusion Pumps Market, by Technology & Connectivity, 2021–2035 (US$ Billion)
TABLE 165: Midwest Region U.S. Large Volume Infusion Pumps Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 166: Illinois Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 167: Ohio Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 168: Michigan Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 169: Minnesota Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 170: Indiana Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 171: Wisconsin Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 172: Missouri Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 173: Iowa Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 174: Kansas Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 175: Nebraska Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 176: North Dakota Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 177: South Dakota Large Volume Infusion Pumps Market: Market Size and Forecast by Pump Architecture, Application, End User, Technology & Connectivity and Procurement Channel, 2021–2035 (US$ Billion)
TABLE 178: U.S. Large Volume Infusion Pumps Market: Competitive Landscape Snapshot, 2025
TABLE 179: U.S. Large Volume Infusion Pumps Market: Key Company Market Share Analysis, 2025
TABLE 180: U.S. Large Volume Infusion Pumps Market: Installed-Base Competitive Positioning
TABLE 181: U.S. Large Volume Infusion Pumps Market: Company Positioning Matrix
TABLE 182: U.S. Large Volume Infusion Pumps Market: Pump Architecture and Channel Capability Benchmarking
TABLE 183: U.S. Large Volume Infusion Pumps Market: DERS, EHR Interoperability and Analytics Capability Benchmarking
TABLE 184: U.S. Large Volume Infusion Pumps Market: Administration Set Portfolio and Recurring Revenue Benchmarking
TABLE 185: U.S. Large Volume Infusion Pumps Market: Cybersecurity, Service and Clinical Implementation Benchmarking
TABLE 186: U.S. Large Volume Infusion Pumps Market: Strategic Developments, Partnerships and Product Launches
TABLE 187: Becton, Dickinson and Company (BD): Company Profile
TABLE 188: Baxter International Inc.: Company Profile
TABLE 189: ICU Medical, Inc.: Company Profile
TABLE 190: Fresenius Kabi: Company Profile
TABLE 191: B. Braun Medical Inc.: Company Profile
TABLE 192: Zyno Medical LLC: Company Profile
TABLE 193: Eitan Medical: Company Profile
TABLE 194: Moog Medical: Company Profile
TABLE 195: Terumo Medical Corporation: Company Profile
TABLE 196: Nipro Medical Corporation: Company Profile
TABLE 197: Cardinal Health, Inc.: Company Profile
TABLE 198: Medline Industries, LP: Company Profile
TABLE 199: McKesson Corporation: Company Profile
TABLE 200: Owens & Minor, Inc.: Company Profile
TABLE 201: Agiliti, Inc.: Company Profile
TABLE 202: InfuSystem Holdings, Inc.: Company Profile
TABLE 203: Epic Systems Corporation: Company Profile
TABLE 204: Oracle Health: Company Profile
TABLE 205: GE HealthCare Technologies Inc.: Company Profile
TABLE 206: Koninklijke Philips N.V.: Company Profile
TABLE 207: Siemens Healthineers AG: Company Profile
TABLE 208: Nihon Kohden America, Inc.: Company Profile
TABLE 209: Avanos Medical, Inc.: Company Profile
TABLE 210: Mindray North America: Company Profile
TABLE 211: Masimo Corporation: Company Profile
TABLE 212: U.S. Large Volume Infusion Pumps Market: Future Market Scenario Analysis, 2026–2035
TABLE 213: U.S. Large Volume Infusion Pumps Market: Disruptive Technologies Impact Matrix
TABLE 214: U.S. Large Volume Infusion Pumps Market: Bidirectional EHR Interoperability Opportunity
TABLE 215: U.S. Large Volume Infusion Pumps Market: AI-Assisted Infusion Analytics Opportunity
TABLE 216: U.S. Large Volume Infusion Pumps Market: Wireless Fleet Management and Predictive Maintenance Outlook
TABLE 217: U.S. Large Volume Infusion Pumps Market: Cybersecurity-by-Design Platform Outlook
TABLE 218: U.S. Large Volume Infusion Pumps Market: Smart Pump Replacement Wave, 2026–2035
TABLE 219: U.S. Large Volume Infusion Pumps Market: Administration Set and Consumable Revenue Outlook
TABLE 220: U.S. Large Volume Infusion Pumps Market: Emerging Business Models
TABLE 221: U.S. Large Volume Infusion Pumps Market: Investment Prioritization Matrix
TABLE 222: U.S. Large Volume Infusion Pumps Market: Strategic Recommendations for Manufacturers
TABLE 223: U.S. Large Volume Infusion Pumps Market: Strategic Recommendations for Hospitals and IDNs
TABLE 224: U.S. Large Volume Infusion Pumps Market: Strategic Recommendations for Pharmacy and Medication-Safety Leaders
TABLE 225: U.S. Large Volume Infusion Pumps Market: Strategic Recommendations for Biomedical Engineering and Clinical Informatics Teams
TABLE 226: U.S. Large Volume Infusion Pumps Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 227: U.S. Large Volume Infusion Pumps Market: Strategic Recommendations for Distributors, GPOs and Service Providers
TABLE 228: U.S. Large Volume Infusion Pumps Market: Strategic Recommendations for New Entrants and Technology Startups
TABLE 229: U.S. Large Volume Infusion Pumps Market: U.S. Go-to-Market Strategy Considerations
TABLE 230: U.S. Large Volume Infusion Pumps Market: Enterprise Hospital Contracting and Conversion Strategy
TABLE 231: U.S. Large Volume Infusion Pumps Market: Product Positioning, Consumables and Interoperability Strategy
TABLE 232: U.S. Large Volume Infusion Pumps Market: Scope Limitation
TABLE 233: U.S. Large Volume Infusion Pumps Market: Market Definition and Revenue Inclusion Limitation
TABLE 234: U.S. Large Volume Infusion Pumps Market: Data Use Limitation
TABLE 235: U.S. Large Volume Infusion Pumps Market: Forecasting Limitation
TABLE 236: U.S. Large Volume Infusion Pumps Market: State-Level Market Estimation Limitation
TABLE 237: U.S. Large Volume Infusion Pumps Market: Company and Competitive Intelligence Limitation
TABLE 238: U.S. Large Volume Infusion Pumps Market: Legal Disclaimer
TABLE 239: U.S. Large Volume Infusion Pumps Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Large Volume Infusion Pumps Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem and Stakeholder Framework
FIGURE 4: Value Chain Analysis
FIGURE 5: Supply Chain Analysis
FIGURE 6: PESTEL Analysis
FIGURE 7: Porter’s Five Forces Analysis
FIGURE 8: Market Attractiveness Analysis
FIGURE 9: Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Clinical Workflow Economics Framework
FIGURE 12: Hospital Capital Procurement Decision Framework
FIGURE 13: Infusion Fleet Replacement-Cycle Framework
FIGURE 14: Smart Pump Interoperability Adoption Framework
FIGURE 15: U.S. Large Volume Infusion Pumps Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 16: U.S. Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 17: U.S. Large Volume Infusion Pumps Market Year-wise Growth Curve, 2021–2035
FIGURE 18: Pump Architecture Segment Market Share Analysis, 2025 & 2035
FIGURE 19: Pump Architecture Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Modular Multi-Channel Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Stand-Alone Single-Channel Pumps Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Dual-Channel Pumps Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Cassette-Based Precision Pumps Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Specialty and MRI-Compatible Pumps Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 26: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Critical Care, Sepsis and Vasoactive Drug Infusion Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Antibiotics, Hydration and General Medical Infusion Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Oncology and Specialty Drug Infusion Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Parenteral Nutrition Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Perioperative and Postoperative Infusion Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Blood Products and Specialty Fluid Management Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 34: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Acute Care Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Academic Medical Centers and Tertiary Care Hospitals Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Specialty Hospitals and Cancer Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Ambulatory Infusion Centers and Hospital Outpatient Departments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Long-Term Acute Care and Post-Acute Settings Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Technology & Connectivity Segment Market Share Analysis, 2025 & 2035
FIGURE 41: Technology & Connectivity Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Smart Pumps with DERS Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: EHR-Interoperable and Auto-Programming Pumps Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Wireless Fleet and Drug-Library Management Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Infusion Analytics and Medication-Safety Platforms Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Cybersecurity-Enabled Connected Platforms Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Conventional and Non-Networked Pumps Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 49: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: IDN Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Distributor and Specialty Medical Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Equipment Leasing, Rental and Managed Fleet Models Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Ambulatory and Alternate-Site Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 57: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: West Region U.S. Large Volume Infusion Pumps Market Share and Leading Players, 2025
FIGURE 59: West Region Market Share Analysis by State, 2025
FIGURE 60: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: California Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Washington Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Arizona Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Colorado Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Oregon Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Utah Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Nevada Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: New Mexico Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Idaho Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Montana Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Wyoming Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Alaska Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Hawaii Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Northeast Region U.S. Large Volume Infusion Pumps Market Share and Leading Players, 2025
FIGURE 75: Northeast Region Market Share Analysis by State, 2025
FIGURE 76: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: New York Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Massachusetts Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: New Jersey Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Pennsylvania Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Connecticut Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Maine Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Vermont Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: New Hampshire Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Rhode Island Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Delaware Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: South Region U.S. Large Volume Infusion Pumps Market Share and Leading Players, 2025
FIGURE 88: South Region Market Share Analysis by State, 2025
FIGURE 89: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Texas Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Florida Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Georgia Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: North Carolina Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Tennessee Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: South Carolina Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Alabama Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Mississippi Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Louisiana Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Arkansas Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Kentucky Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Oklahoma Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Virginia Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Maryland Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: West Virginia Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Midwest Region U.S. Large Volume Infusion Pumps Market Share and Leading Players, 2025
FIGURE 106: Midwest Region Market Share Analysis by State, 2025
FIGURE 107: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Illinois Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Ohio Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Michigan Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Minnesota Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Indiana Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Wisconsin Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Missouri Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Iowa Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Kansas Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Nebraska Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: North Dakota Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: South Dakota Large Volume Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 121: Installed-Base Competitive Positioning
FIGURE 122: Company Positioning Matrix
FIGURE 123: Pump Architecture and Channel Capability Benchmarking
FIGURE 124: DERS, EHR Interoperability and Analytics Capability Benchmarking
FIGURE 125: Administration Set and Recurring Revenue Benchmarking
FIGURE 126: Cybersecurity, Service and Clinical Implementation Benchmarking
FIGURE 127: Strategic Developments, Partnerships and Product Launches
FIGURE 128: Large Volume Infusion Pump Innovation Roadmap
FIGURE 129: Bidirectional EHR Interoperability Adoption Roadmap
FIGURE 130: AI-Assisted Infusion Analytics Opportunity Map
FIGURE 131: Wireless Fleet Management and Predictive Maintenance Roadmap
FIGURE 132: Cybersecurity-by-Design Infusion Platform Roadmap
FIGURE 133: Smart Pump Replacement Wave, 2026–2035
FIGURE 134: Future Market Scenario Analysis, 2026–2035
FIGURE 135: Disruptive Technologies Impact Matrix
FIGURE 136: Emerging Business Models Matrix
FIGURE 137: Investment Prioritization Matrix
FIGURE 138: Strategic Growth Roadmap for U.S. Large Volume Infusion Pump Companies
FIGURE 139: Go-to-Market Strategy Framework
FIGURE 140: Enterprise Hospital Contracting and Conversion Framework
FIGURE 141: Product Positioning and Portfolio Expansion Framework
FIGURE 142: Consumables and Interoperability Commercialization Framework
FIGURE 143: Report Scope and Disclaimer Framework